Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2021 Volume 22 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2021 Volume 22 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma

  • Authors:
    • Dan Costachescu
    • Ioana Ionita
    • Ema-Cristina Borsi
    • Ovidiu Potre
    • Cristina Potre
    • Dan-Bogdan Navolan
    • Alexandru Blidisel
    • Hortensia Ionita
    • Adelina Erimescu
    • Gheorghe Nicusor Pop
    • Daniel Claudiu Malita
  • View Affiliations / Copyright

    Affiliations: Department of Radiology, ‘Victor Babes’ University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania, Department of Hematology, ‘Victor Babes’ University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania, Department of Obstetrics and Gynecology, ‘Victor Babes’ University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania, Department of Surgery, ‘Victor Babes’ University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania, Center for Modeling Biological Systems and Data‑Analysis, Department of Functional Sciences, ‘Victor Babes’ University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania
    Copyright: © Costachescu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 827
    |
    Published online on: June 3, 2021
       https://doi.org/10.3892/etm.2021.10259
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Multiple myeloma (MM) is a neoplasm of the B lymphocytes characterized by the uncontrolled proliferation of a plasmocyte clone. Magnetic resonance imaging (MRI) remains the most sensitive and specific imaging method for the detection of bone marrow infiltration, before macroscopic bone changes are visible, with evidence that the detection rate and overall performance of MRI could be enhanced by applying diffusion‑weighted imaging (DWI). The aim of our research was to evaluate whether measuring apparent diffusion coefficient (ADC) values in newly diagnosed patients with MM could be a prognostic factor for the course of the disease and to ascertain whether there is any correlation with other prognostic factors in MM. A retrospective study was performed on a group of 32 patients with newly diagnosed MM that underwent at least two whole‑body (WB)‑MRIs; one before and one after induction therapy. Patients with advanced stage of disease showed an increased ADC value: Stage 2 vs. stage 1 (1.162 vs. 0.289, P=0.033), respectively, stage 3 vs. stage 1 (0.867 vs. 0.289, P=0.041). In addition, ADC values were inversely correlated with survival time: r=‑0.641, P<0.001. According to the multivariate linear regression model, we observed that for every point of ADC value (before treatment) the survival was decreased/reduced by 14.5 months. Moreover, bortezomib therapy predicted an increase in the survival length/duration by 7.9 months. Our regression equation proved to be a good fit for the model, explaining 57.8% of survival duration (adjusted R2=0.578). In conclusion, the negative prognostic factors associated with WB‑MRI are represented by high ADC values before treatment (for every point of ADC the survival was decreased by 14.5 months) and focal/diffuse marrow involvement.
View Figures

Figure 1

View References

1 

Fairfield H, Falank C, Avery L and Reagan MR: Multiple myeloma in the marrow: Pathogenesis and treatments. Ann NY Acad Sci. 1364:32–51. 2016.PubMed/NCBI View Article : Google Scholar

2 

Mena E, Choyke P, Tan E, Landgren O and Kurdziel K: Molecular imaging in myeloma precursor disease. Semin Hematol. 48:22–31. 2011.PubMed/NCBI View Article : Google Scholar

3 

Caers J, Withofs N, Hillengass J, Simoni P, Zamagni E, Hustinx R and Beguin Y: The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma. Haematologica. 99:629–637. 2014.PubMed/NCBI View Article : Google Scholar

4 

Dutoit JC and Verstraete KL: MRI in multiple myeloma: A pictorial review of diagnostic and post-treatment findings. Insights Imaging. 7:553–569. 2016.PubMed/NCBI View Article : Google Scholar

5 

Koutoulidis V, Papanikolaou N and Moulopoulos LA: Functional and molecular MRI of the bone marrow in multiple myeloma. Br J Radiol. 91(20170389)2018.PubMed/NCBI View Article : Google Scholar

6 

Dietrich O, Biffar A, Baur-Melnyk A and Reiser MF: Technical aspects of MR diffusion imaging of the body. Eur J Radiol. 76:314–322. 2010.PubMed/NCBI View Article : Google Scholar

7 

Messiou C, Giles S, Collins DJ, West S, Davies FE, Morgan GJ and Desouza NM: Assessing response of myeloma bone disease with diffusion-weighted MRI. Br J Radiol. 85:e1198–e1203. 2012.PubMed/NCBI View Article : Google Scholar

8 

Messiou C and Kaiser M: Whole body diffusion weighted MRI-a new view of myeloma. Br J Haematol. 171:29–37. 2015.PubMed/NCBI View Article : Google Scholar

9 

Kwee TC, Takahara T, Ochiai R, Katahira K, van Cauteren M, Imai Y, Nievelstein RA and Lujiten PR: Whole-body diffusion-weighted magnetic resonance imaging. Eur J Radiol. 70:409–417. 2009.PubMed/NCBI View Article : Google Scholar

10 

Dutoit JC and Verstraete KL: Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma. Skeletal Radiol. 46:733–750. 2017.PubMed/NCBI View Article : Google Scholar

11 

Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, et al: International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 17:e328–e346. 2016.PubMed/NCBI View Article : Google Scholar

12 

He J, Fang H and Na Li X: Vertebral bone marrow diffusivity in normal adults with varying bone densities at 3T diffusion-weighted imaging. Acta Radiol. 59:89–96. 2018.PubMed/NCBI View Article : Google Scholar

13 

Griffith JF, Yeung DK, Ma HT, Leung JC, Kwok TC and Leung PC: Bone marrow fat content in the elderly: A reversal of sex difference seen in younger subjects. J Magn Reson Imaging. 36:225–230. 2012.PubMed/NCBI View Article : Google Scholar

14 

D'Anastasi M, Notohamiprodjo M, Schmidt GP, Dürr HR, Reiser MF and Baur-Melnyk A: Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI. AJR Am J Roentgenol. 203:854–862. 2014.PubMed/NCBI View Article : Google Scholar

15 

Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, Raje N, Sezer O, Zweegman S, Shah J, et al: Role of magnetic resonance imaging in the management of patients with multiple myeloma: A consensus statement. J Clin Oncol. 33:657–664. 2015.PubMed/NCBI View Article : Google Scholar

16 

Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, Hillengass J, Engelhardt M, Usmani SZ, Vesole DH, et al: Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: A consensus statement by the International Myeloma Working Group. Lancet Oncol. 18:e206–e217. 2017.PubMed/NCBI View Article : Google Scholar

17 

Argyropoulos CP, Chen SS, Ng YH, Roumelioti ME, Shaffi K, Singh PP and Tzamaloukas AH: Rediscovering beta-2 Microglobulin as a biomarker across the spectrum of kidney diseases. Front Med (Lausanne). 4(73)2017.PubMed/NCBI View Article : Google Scholar

18 

Borsi E, Bucur A, Oncu CP, Oncu OP, Cerbu B, Costachescu D, Ionita I, Luca CT and Ionita H: First line therapy in multiple myeloma: Vad vs. bortezomib-dexamethasone. Rev Chim. 70:1017–1022. 2019.

19 

Pawlyn C and Davies FE: Toward personalized treatment in multiple myeloma based on molecular characteristics. Blood. 133:660–675. 2019.PubMed/NCBI View Article : Google Scholar

20 

de Souza NM, Winfield JM, Waterton JC, Weller A, Papoutsaki MV, Doran SJ, Collins DJ, Fournier L, Sullivan D, Chenevert T, et al: Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: Current considerations and future perspectives. Eur Radiol. 28:1118–1131. 2018.PubMed/NCBI View Article : Google Scholar

21 

Wu C, Huang J, Xu WB, Guan YJ, Ling HW, Mi JQ and Yan H: Discriminating depth of response to therapy in multiple myeloma using whole-body diffusion-weighted MRI with apparent diffusion coefficient: Preliminary results from a single-center study. Acad Radiol. 25:904–914. 2018.PubMed/NCBI View Article : Google Scholar

22 

Mosavi F, Wassberg C, Selling J, Molin D and Ahlstrom H: Whole-body diffusion-weighted MRI and 18F-FDG PET/CT can discriminate between different lymphoma subtypes. Clin Radiol. 70:1229–1236. 2015.PubMed/NCBI View Article : Google Scholar

23 

Bonaffini PA, Ippolito D, Casiraghi A, Besostri V, Franzesi CT and Sironi S: Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma. Acad Radiol. 22:1163–1171. 2015.PubMed/NCBI View Article : Google Scholar

24 

Messiou C and Kaiser M: Whole-Body imaging in multiple myeloma. Magn Reson Imaging Clin N Am. 26:509–525. 2018.PubMed/NCBI View Article : Google Scholar

25 

Giles SL, Messiou C, Collins DJ, Morgan VA, Simpkin CJ, West S, Davies FE, Morgan GJ and de Souza NM: Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. Radiology. 271:785–794. 2014.PubMed/NCBI View Article : Google Scholar

26 

Koh DM and Thoeny HC (eds): MRI for Disease Detection. In: Diffusion-weighted MR imaging, medical radiology. Springer Berlin, Heidelberg, pp97-115, 2010.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Costachescu D, Ionita I, Borsi E, Potre O, Potre C, Navolan D, Blidisel A, Ionita H, Erimescu A, Pop GN, Pop GN, et al: Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma. Exp Ther Med 22: 827, 2021.
APA
Costachescu, D., Ionita, I., Borsi, E., Potre, O., Potre, C., Navolan, D. ... Malita, D.C. (2021). Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma. Experimental and Therapeutic Medicine, 22, 827. https://doi.org/10.3892/etm.2021.10259
MLA
Costachescu, D., Ionita, I., Borsi, E., Potre, O., Potre, C., Navolan, D., Blidisel, A., Ionita, H., Erimescu, A., Pop, G. N., Malita, D. C."Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma". Experimental and Therapeutic Medicine 22.2 (2021): 827.
Chicago
Costachescu, D., Ionita, I., Borsi, E., Potre, O., Potre, C., Navolan, D., Blidisel, A., Ionita, H., Erimescu, A., Pop, G. N., Malita, D. C."Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma". Experimental and Therapeutic Medicine 22, no. 2 (2021): 827. https://doi.org/10.3892/etm.2021.10259
Copy and paste a formatted citation
x
Spandidos Publications style
Costachescu D, Ionita I, Borsi E, Potre O, Potre C, Navolan D, Blidisel A, Ionita H, Erimescu A, Pop GN, Pop GN, et al: Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma. Exp Ther Med 22: 827, 2021.
APA
Costachescu, D., Ionita, I., Borsi, E., Potre, O., Potre, C., Navolan, D. ... Malita, D.C. (2021). Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma. Experimental and Therapeutic Medicine, 22, 827. https://doi.org/10.3892/etm.2021.10259
MLA
Costachescu, D., Ionita, I., Borsi, E., Potre, O., Potre, C., Navolan, D., Blidisel, A., Ionita, H., Erimescu, A., Pop, G. N., Malita, D. C."Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma". Experimental and Therapeutic Medicine 22.2 (2021): 827.
Chicago
Costachescu, D., Ionita, I., Borsi, E., Potre, O., Potre, C., Navolan, D., Blidisel, A., Ionita, H., Erimescu, A., Pop, G. N., Malita, D. C."Whole‑body diffusion‑weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma". Experimental and Therapeutic Medicine 22, no. 2 (2021): 827. https://doi.org/10.3892/etm.2021.10259
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team